V-Square Quantitative Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

V-Square Quantitative Management’s Portfolio AMLX Stock Details AMLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$23.8K	Buy	+819	New	+$21.7K	﹤0.01%	683

Other funds holding AMLX

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

PPWP

Premier Path Wealth Partners Madison, New Jersey $856M AUM 23.55% 1-Year Est. Return

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

CAIM

Catherine Avery Investment Management Longboat Key, Florida $116M AUM 31.75% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

V-Square Quantitative Management's AMLX Position: Q3 2026 in Review

V-Square Quantitative Management opened a new position in Amylyx Pharmaceuticals (AMLX) in Q3 2026: 819 shares worth $23.8K. The stake represents ﹤0.01% of the portfolio and ranks #683 among its holdings.

12 funds tracked by Wall St. Rank hold AMLX as of Q3 2026.

V-Square Quantitative Management held 819 shares of Amylyx Pharmaceuticals worth $23.8K as of Q3 2026.
Amylyx Pharmaceuticals was a new V-Square Quantitative Management position in Q3 2026.
Amylyx Pharmaceuticals made up ﹤0.01% of V-Square Quantitative Management's portfolio in Q3 2026, its #683 holding.
12 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2026.

Based on V-Square Quantitative Management's 13F filing for Q3 2026, filed 15 Oct 2026.